Journal of Computer-Aided Molecular Design

, Volume 25, Issue 7, pp 607–610

Fragment-based lead discovery: challenges and opportunities

  • Chaohong Sun
  • Andrew M. Petros
  • Philip J. Hajduk
Article

DOI: 10.1007/s10822-011-9451-z

Cite this article as:
Sun, C., Petros, A.M. & Hajduk, P.J. J Comput Aided Mol Des (2011) 25: 607. doi:10.1007/s10822-011-9451-z

Abstract

Fragment-based lead discovery has undergone remarkable changes over the last 15 years. During this time, the pharmaceutical industry has changed dramatically as well, and continued evolution of the industry is assured. These changes present many challenges but also several opportunities for executing fragment-based drug design. This article will explore some of the more significant changes in the industry and how they may affect future discovery efforts related to fragment-based initiatives.

Keywords

Fragment-based drug designBiologicsOff-shoringOutsourcing

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Chaohong Sun
    • 1
  • Andrew M. Petros
    • 1
  • Philip J. Hajduk
    • 1
  1. 1.Pharmaceutical Discovery DivisionAbbott LaboratoriesAbbott ParkUSA